Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
2.920
-0.120 (-3.95%)
At close: Nov 20, 2024, 4:00 PM
2.870
-0.050 (-1.71%)
Pre-market: Nov 21, 2024, 5:50 AM EST
SONN Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 |
| Revenue | 0.06 | 0.15 | 0.35 | 0.48 | - | - | |
| Revenue Growth (YoY) | -67.76% | -57.76% | -27.64% | - | - | - | |
| Cost of Revenue | 6.38 | 11.81 | 21.44 | 16.63 | 9.88 | - | |
| Gross Profit | -6.33 | -11.67 | -21.09 | -16.15 | -9.88 | - | |
| Selling, General & Admin | 5.95 | 7.13 | 8.58 | 8.94 | 7.53 | 2.51 | |
| Research & Development | - | - | - | - | - | 2.2 | |
| Operating Expenses | 5.95 | 7.13 | 8.58 | 8.94 | 7.53 | 4.71 | |
| Operating Income | -12.28 | -18.79 | -29.67 | -25.09 | -17.41 | -4.71 | |
| Interest Expense | - | - | - | - | - | -0.16 | |
| Interest & Investment Income | - | - | - | 0 | 0.02 | - | |
| Currency Exchange Gain (Loss) | -0.04 | -0.04 | -0.05 | -0.02 | -0.05 | - | |
| EBT Excluding Unusual Items | -7.99 | -18.83 | -29.72 | -25.11 | -17.44 | -4.87 | |
| Other Unusual Items | - | - | - | 0.13 | - | - | |
| Pretax Income | -7.99 | -18.83 | -29.72 | -24.98 | -24.27 | -4.87 | |
| Net Income | -7.99 | -18.83 | -29.72 | -24.98 | -24.27 | -4.87 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | 41.34 | - | |
| Net Income to Common | -7.99 | -18.83 | -29.72 | -24.98 | -65.6 | -4.87 | |
| Shares Outstanding (Basic) | 3 | 0 | 0 | - | - | - | |
| Shares Outstanding (Diluted) | 3 | 0 | 0 | - | - | - | |
| Shares Change (YoY) | 377.77% | 425.76% | - | - | - | - | |
| EPS (Basic) | -2.76 | -145.12 | -1204.14 | - | - | - | |
| EPS (Diluted) | -2.76 | -145.12 | -1204.14 | - | - | - | |
| Free Cash Flow | -10 | -21.34 | -27.77 | -22.56 | -15.69 | -2.23 | |
| Free Cash Flow Per Share | -3.46 | -164.45 | -1125.21 | - | - | - | |
| Operating Margin | -21968.54% | -12714.47% | -8478.34% | -5187.36% | - | - | |
| Profit Margin | -14289.97% | -12741.58% | -8493.34% | -5165.97% | - | - | |
| Free Cash Flow Margin | -17889.20% | -14439.19% | -7936.59% | -4663.91% | - | - | |
| EBITDA | -12.26 | -18.78 | -29.66 | -25.07 | -17.4 | - | |
| D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | - | |
| EBIT | -12.28 | -18.79 | -29.67 | -25.09 | -17.41 | -4.71 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.